Glucose-Dependent Insulinotropic Polypeptide Plasma Level Influences the Effect of n-3 PUFA Supplementation

Elevated glucose-dependent insulinotropic peptide (GIP) levels in obesity may predict the metabolic benefits of n-3 PUFA supplementation. This placebo-controlled trial aimed to analyze fasting and postprandial GIP response to 3-month n-3 PUFA supplementation (1.8 g/d; DHA:EPA, 5:1) along with calori...

Descripción completa

Detalles Bibliográficos
Autores principales: Goralska, Joanna, Razny, Urszula, Calder, Philip C., Gruca, Anna, Childs, Caroline E., Zabielski, Piotr, Dembinska-Kiec, Aldona, Banach, Maciej, Solnica, Bogdan, Malczewska-Malec, Malgorzata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406980/
https://www.ncbi.nlm.nih.gov/pubmed/36010335
http://dx.doi.org/10.3390/diagnostics12081984

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406980/
https://www.ncbi.nlm.nih.gov/pubmed/36010335
http://dx.doi.org/10.3390/diagnostics12081984

Ejemplares similares